Kenya Hematology Market Analysis


  • Type: Therapeutics Area
  • Published : June 2021
  • Region: Africa
  • Country: Kenya
  • Report ID : 4824

  • Format: PPT, PDF

Kenya Hematologic Drug Market: Segmented by Disease types (Anaemia, Sickle Cell Disease, Haemophilia, Thalassemia, Thrombocytopenia, Thrombocytosis, Blood Cancers and Other Applications), Drug Class (Iron and Folic Acid Supplements, Anti-Metabolites, Desmopressin, Plasma-derived coagulation factor concentrates, Recombinant coagulation factor concentrates, Antifibrinolytics and Other Drug Classes), Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online and Others) – Growth, Trends, and Forecasts (2019 – 2028)

SKU: 4824 Categories: ,

Report Overview

The Hematologic Drug market size in Kenya stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Anaemia has long been recognised as a major public health problem among young children and women of child-bearing age in lower- and middle-income countries and is an indicator of poor nutrition and health status. Approximately one in four Kenyan children aged <15 years were described as anaemic, including 12% with WHO-defined moderate anaemia and 1% were severely anaemic. In a study conducted to determine prevalence of anaemia in pregnant women in Kenya, it was found that 40% were anaemic, of which 62.5% were mildly anaemic and 37.5 % were moderately anaemic. Hookworm infestation, malaria and HIV infections contribute immensely to anaemia cases reported in pregnant women. Sickle cell disease (SCD) is a genetic disorder that affects the haemoglobin (Hb) molecule. As per the estimate, 12-15 million SCD patients are living in Africa. According to the American Society of Haematology, the prevalence of SCD is anticipated to increase by 30% by 2050.

Market Drivers

The market is majorly driven by the rising burden of Hematologic diseases. Sickle cell disease (SCD) is the most common hemoglobinopathy encountered in Kenya. In the western part of the country, about 4.5% of children are born with SCD, and 18% of children are born with sickle cell trait. The rising prevalence of sickle Cell Disease in Africa is one of the major factors to augment growth of the market.

The increasing incidence of Blood Cancers in Kenya is also driving the growth of the market.  Cancer in Africa is an emerging health problem. Chronic Leukaemia accounts for 5.4% of all the cancer cases in the country.

Development of new products by pharmaceutical companies has led to growth in the sickle cell Drug market. The New drug by Novartis AG (Adakveo) has been approved by FDA as treatment in sickle cell disease.

However, the high cost of treatment imposes significant financial burden on patients, lack of donors and postponement of blood transfusion procedures during the pandemic are among the restraining factors for growth in the hematologic drug market.

1. Kenya Hematologic Drug Market Overview…………………………………………….
A. Market Size
2. Market Growth Drivers………………………………………………………………
A. High Prevalence of Anaemia and Sickle Cell Disease (SCD)
B. Increase in Incidence of Blood Cancers
C. Development of New Drugs and Available Therapies
3. Major Hematologic Diseases ………………………………………………………
A. Anaemia
B. Sickle Cell Disease
C. Haemophilia
D. Thalassemia
E. Thrombocytosis
F. Thrombocytopenia
G. Blood Cancers
H. Others
4. Hematologic Drug Market Segmentation……………………………………………….
A. Drug Class
I. Iron and Folic Acid Supplements
II. Anti-Metabolites
III. Desmopressin
IV. Anti-Fibrinolytics
V. Plasma-Derived Coagulation Factor Concentrates
VI. Recombinant Coagulation Factor Concentrates
VII. Others
B. Distribution Channels
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online
IV. Others
5. Hematologic Major Products Market Share……………………………………..
A. Key Findings
B. Market Analysis, Insights and Forecast – By Drug Type
6. Competitive Landscape……………………………………………………………….
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………
A. Hoffmann-La Roche Company overview, Product & Services, Strategies & Financials
B. Pfizer, Inc. Company overview, Product & Services, Strategies & Financials
C. Novartis Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape……………………………….
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………………
A. New Trends and Development of Hematologic drug market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Disease Type:

On the basis of disease type, the hematologic drug market can be segmented into Anaemia, Sickle Cell Disease, Haemophilia, Thalassemia, Thrombocytosis, Thrombocytopenia, Blood cancers and others.

By Drug Class:

On the basis of drug class, the hematologic drug market in Kenya, can be segmented into Iron and Folic Acid Supplements, Anti-metabolites, Desmopressin, Anti-Fibrinolytics, and Blood Transfusion procedures like Plasma-Derived Coagulation Factor Concentrates and Recombinant Coagulation Factor Concentrates.

Hydroxyurea is a first line drug in treatment of sickle cell disease, is expected to witness fastest growth rate in the hematologic Drug market.

By Distribution Channels:

On the basis of distribution channels, the market is segmented into hospital pharmacies, retail pharmacies, online and others.

Major Players

The Hematologic drug market in Kenya is majorly driven due to the high burden of sickle cell disease. In terms of Sickle Cell Disease treatment market revenue, Novartis AG accounted for the dominant position. The company entered the market with the approval of Adakveo in 2019, the drug can reduce sickle cell pain crisis by 45% in clinical trials.

Bristol-Myers Squibb Company is also leading in the sickle cell disease drug market with its blockbuster drugs Hydrea and Droxia.

Other Key players leading the market are Hoffmann-La Roche, Pfizer, Inc., AstraZeneca and Bayer.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements